CIVIS announces the opening of the registration for the CIVIS programme “Technical innovations in basic and translational research: applications to immunology-oncology”.
The programme aims to help MA and PhD students to learn how new technologies are turning the latest discoveries in basic research into innovative methods for analysis and treatment in immuno-oncology.
The programme will take place in a blended format during the academic year 2021-2022:
- Until the end of November 2021 – virtual component: students will follow 5 e-learning courses and will apply for the physical mobility component.
- December 2021 – exams on online courses and review of applications for the physical mobility component.
- January – June 2022 – mobility component: short-term physical mobility to visit scientific platforms, followed by corresponding exam.
- July 2022 – completion and certification of the programme.
The programme is open to Master’s and PhD students at CIVIS Alliance universities specialized in Natural Sciences and Mathematics, Medicine and Health. Full details of the programme and the application process can be found on the dedicated page. The online courses will be open to a broad audience of relevant students, of whom 25 will be selected for the mobility component. The deadline for application is 30 September 2021.
This programme aims to prepare tomorrow’s scientists and medical doctors for the impending evolution of current paradigms in immuno-oncology. We will do this by approaching the questions from a technical perspective, through a blended mobility curriculum where teaching is focused on technical applications in fundamental, translational and clinical immuno-oncology.
Students will receive the technical theoretical bases enabling them to understand the functioning of these innovative technologies, as well as the applications to the exploration of anti-tumor immunity in aspects ranging from the fundamental research to the clinical approaches. The critical step of data analysis using machine learning algorithms will also be addressed in the different themes.
More details about the intensive CIVIS Course “Technical innovations in basic and translational research: applications to immunology-oncology” are also available on the CIVIS webpage, here.
CIVIS is a European Civic University formed by the alliance of nine leading research higher education institutions across Europe: Aix-Marseille Université, National and Kapodistrian University of Athens, Universitatea din București, Université libre de Bruxelles, Universidad Autónoma de Madrid, Sapienza Università di Roma, Stockholm University, Eberhard Karls Universität Tübingen and University of Glasgow. It brings together a community of more than 450,000 students and 65,000 staff members including 30,000 academics and researchers.